论文部分内容阅读
目的:通过对2004-2006年我院419例结石性胆囊炎患者使用抗菌药物的调查与分析,为临床治疗结石性胆囊炎提供理论依据。方法:通过抽取我院2004-2006年所有结石性胆囊炎患者的病历,对其抗菌药应用情况进行统计分析,以药物利用指数(DUI)作为分析判断指标。结果:DUI为0.9~1.1品种有10种,占50.00%;DUI<0.9的品种有3种,占15.00%;DUI>1.1的品种有7种,占35.00%。平均每人用1.5种抗菌药物,每日抗菌药费为25.34元。结论:我院对结石性胆囊炎患者的抗菌药物应用基本合理,但存在抗菌药物联合使用不当、频繁更换抗菌药物等问题。
OBJECTIVE: To provide a theoretical basis for the clinical treatment of stone cholecystitis by investigating and analyzing the use of antibacterials in 419 cases of calcific cholecystitis in our hospital from 2004 to 2006. Methods: The medical records of all patients with calcific cholecystitis in our hospital from 2004 to 2006 were collected for statistical analysis of the application of antibacterials. The drug utilization index (DUI) was taken as the index for analysis and judgment. Results: There were 10 species with DUI ranging from 0.9 to 1.1, accounting for 50.00%, 3 species with DUI <0.9, accounting for 15.00%, and 7 species with DUI> 1.1 accounting for 35.00%. An average of 1.5 kinds of antibacterial drugs per person, the daily antibacterial drug costs of 25.34 yuan. Conclusion: The application of antimicrobial agents in patients with calcific cholecystitis is reasonable in our hospital, but there are some problems such as improper use of antimicrobial agents and frequent replacement of antimicrobial agents.